Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TOP2A | P11388 | 1/20 | 0.44 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9755399 | 0.91 | KDM1A (0.48) | KDM1AACHEKMT2ANPSR1TOP2A | |
| SCHEMBL9755413 | 0.89 | TOP2A (0.50) | KDM1AKMT2ATOP2ATOP2BMEN1 | |
| SCHEMBL9755350 | 0.86 | KDM1A (0.45) | KDM1AACHEKMT2ANPSR1TOP2A | |
| SCHEMBL9755337 | 0.80 | KMT2A (0.42) | KDM1AACHEKMT2ANPSR1TOP2A | |
| SCHEMBL9755438 | 0.80 | KDM1A (0.53) | KDM1AKMT2ANPSR1TOP2ATOP2B | |
| SCHEMBL9755414 | 0.77 | KDM1A (0.45) | KDM1AACHEKMT2ANPSR1TOP2A | |
| SCHEMBL9755373 | 0.76 | ACHE (0.39) | KDM1AACHEKMT2ANPSR1MEN1 | |
| SCHEMBL9755390 | 0.76 | TOP2A (0.55) | KDM1AKMT2ATOP2ATOP2BMEN1 | |
| SCHEMBL9755355 | 0.75 | KDM1A (0.50) | KDM1AKMT2ANPSR1TOP2ATOP2B | |
| SCHEMBL9594083 | 0.74 | KDM1A (0.67) | KDM1ATOP2ATOP2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991005770-A1 | POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1991-05-02 | — | — | WO | disclosed |